Literature DB >> 33031942

Molecular Pathways Linking Oxylipins to Nociception in Rats.

Anthony F Domenichiello1, Matthew R Sapio2, Amelia J Loydpierson2, Dragan Maric3, Taichi Goto4, Mark S Horowitz5, Gregory S Keyes5, Zhi-Xin Yuan5, Sharon F Majchrzak-Hong6, Andrew J Mannes2, Michael J Iadarola2, Christopher E Ramsden7.   

Abstract

Oxylipins are lipid peroxidation products that participate in nociceptive, inflammatory, and vascular responses to injury. Effects of oxylipins depend on tissue-specific differences in accumulation of precursor polyunsaturated fatty acids and the expression of specific enzymes to transform the precursors. The study of oxylipins in nociception has presented technical challenges leading to critical knowledge gaps in the way these molecules operate in nociception. We applied a systems-based approach to characterize oxylipin precursor fatty acids, and expression of genes coding for proteins involved in biosynthesis, transport, signaling and inactivation of pro- and antinociceptive oxylipins in pain circuit tissues. We further linked these pathways to nociception by demonstrating intraplantar carrageenan injection induced gene expression changes in oxylipin biosynthetic pathways. We determined functional-biochemical relevance of the proposed pathways in rat hind paw and dorsal spinal cord by measuring basal and stimulated levels of oxylipins throughout the time-course of carrageenan-induced inflammation. Finally, when oxylipins were administered by intradermal injection we observed modulation of nociceptive thermal hypersensitivity, providing a functional-behavioral link between oxylipins, their molecular biosynthetic pathways, and involvement in pain and nociception. Together, these findings advance our understanding of molecular lipidomic systems linking oxylipins and their precursors to nociceptive and inflammatory signaling pathways in rats. PERSPECTIVE: We applied a systems approach to characterize molecular pathways linking precursor lipids and oxylipins to nociceptive signaling. This systematic, quantitative evaluation of the molecular pathways linking oxylipins to nociception provides a framework for future basic and clinical research investigating the role of oxylipins in pain. Published by Elsevier Inc.

Entities:  

Keywords:  Oxylipin; RNASeq; lipids; liquid chromatography tandem-mass spectrometry; pain

Mesh:

Substances:

Year:  2020        PMID: 33031942      PMCID: PMC7954900          DOI: 10.1016/j.jpain.2020.09.001

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  108 in total

1.  The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat.

Authors:  B D Grubb; G J Birrell; D S McQueen; A Iggo
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Oxidative metabolism of linoleic acid by human leukocytes.

Authors:  O Reinaud; M Delaforge; J L Boucher; F Rocchiccioli; D Mansuy
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

3.  Labour is associated with decreased expression of the PGF2alpha receptor (PTGFR) and a novel PTGFR splice variant in human myometrium but not decidua.

Authors:  Andrea Hay; Stephen Wood; David Olson; Donna M Slater
Journal:  Mol Hum Reprod       Date:  2010-06-02       Impact factor: 4.025

4.  Nociception and inflammatory hyperalgesia evaluated in rodents using infrared laser stimulation after Trpv1 gene knockout or resiniferatoxin lesion.

Authors:  Kendall Mitchell; Evan E Lebovitz; Jason M Keller; Andrew J Mannes; Michael I Nemenov; Michael J Iadarola
Journal:  Pain       Date:  2014-01-13       Impact factor: 6.961

5.  The Genotype-Tissue Expression (GTEx) project.

Authors: 
Journal:  Nat Genet       Date:  2013-06       Impact factor: 38.330

Review 6.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 7.  Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer.

Authors:  Guodong Zhang; Sean Kodani; Bruce D Hammock
Journal:  Prog Lipid Res       Date:  2013-12-15       Impact factor: 16.195

8.  A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M.

Authors:  Z Weng; A C Fluckiger; S Nisitani; M I Wahl; L Q Le; C A Hunter; A A Fernal; M M Le Beau; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain.

Authors:  Shivani Ruparel; Dustin Green; Paul Chen; Kenneth M Hargreaves
Journal:  Mol Pain       Date:  2012-09-24       Impact factor: 3.395

10.  Dietary linoleic acid-induced alterations in pro- and anti-nociceptive lipid autacoids: Implications for idiopathic pain syndromes?

Authors:  Christopher E Ramsden; Amit Ringel; Sharon F Majchrzak-Hong; Jun Yang; Helene Blanchard; Daisy Zamora; James D Loewke; Stanley I Rapoport; Joseph R Hibbeln; John M Davis; Bruce D Hammock; Ameer Y Taha
Journal:  Mol Pain       Date:  2016-03-10       Impact factor: 3.395

View more
  3 in total

1.  The need for precision nutrition, genetic variation and resolution in Covid-19 patients.

Authors:  Artemis P Simopoulos; Charles N Serhan; Richard P Bazinet
Journal:  Mol Aspects Med       Date:  2021-01-28

2.  Circulating Omega-6 and Omega-3 Polyunsaturated Fatty Acids in Painful Temporomandibular Disorder and Low Back Pain.

Authors:  Anne E Sanders; E Diane Weatherspoon; Brandie M Ehrmann; Paul S Soma; Saame R Shaikh; John S Preisser; Richard Ohrbach; Roger B Fillingim; Gary D Slade
Journal:  J Pain       Date:  2022-06-10       Impact factor: 5.383

3.  Longitudinal peripheral tissue RNA-Seq transcriptomic profiling, hyperalgesia, and wound healing in the rat plantar surgical incision model.

Authors:  Taichi Goto; Matthew R Sapio; Dragan Maric; Jeffrey M Robinson; Anthony F Domenichiello; Leorey N Saligan; Andrew J Mannes; Michael J Iadarola
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.